atopic dermatitis
FDA Grants New Indication for Dupixent for Young Children With Atopic Dermatitis
The new indication for children ranging from 6 months to 5 years of age makes Dupixent the first biologic approved ...
JUNE 8, 2022
Rinvoq Now Indicated to Treat Severe Atopic Dermatitis
The FDA granted a new indication for Rinvoq, AbbVie to treat severe atopic dermatitis in adults and children aged ...
JANUARY 18, 2022
FDA Approves Eucrisa for Atopic Dermatitis
Crisaborole, applied topically twice daily, is a phosphodiesterase-4 (PDE-4) inhibitor.
DECEMBER 15, 2016
Load more